A proposed HHS rule "to strengthen Medicare Advantage and Medicare Part D prescription drug coverage" also includes a proposed update "to the Medicare Part D medication therapy management (MTM) program to improve access, including a proposed requirement that plans include all 10 core chronic diseases identified by CMS — including HIV/AIDS — in their MTM targeting criteria."
Comments are due February 13, 2023. Read more in HHS Proposes Rule to Strengthen Beneficiary Protections, Improve Access to Behavioral Health Care, and Promote Equity for Millions of Americans with Medicare Advantage and Medicare Part D.